Healthcare provider profile · identity verified

Hermon Mesfin, FNP

Nurse Practitioner · DUMFRIES, VA · NPI 1760157374

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	661	97
Levothyroxine Sodium	Levothyroxine Sodium	417	65
Furosemide	Furosemide	345	57
Amlodipine Besylate	Amlodipine Besylate	328	52
Eliquis	Apixaban	276	37
Donepezil Hcl	Donepezil Hcl	270	43
Gabapentin	Gabapentin	239	38
Escitalopram Oxalate	Escitalopram Oxalate	233	33
Metoprolol Succinate	Metoprolol Succinate	233	32
Lisinopril	Lisinopril	202	29
Mirtazapine	Mirtazapine	177	26
Metformin Hcl	Metformin Hcl	167	28
Trazodone Hcl	Trazodone Hcl	164	32
Losartan Potassium	Losartan Potassium	160	30
Quetiapine Fumarate	Quetiapine Fumarate	146	34
Memantine Hcl	Memantine Hcl	139	21
Omeprazole	Omeprazole	138	24
Potassium Chloride	Potassium Chloride	134	27
Pantoprazole Sodium	Pantoprazole Sodium	131	21
Torsemide	Torsemide	130	22
Tamsulosin Hcl	Tamsulosin Hcl	120	19
Sertraline Hcl	Sertraline Hcl	110	19
Tramadol Hcl	Tramadol Hcl	104	33
Metoprolol Tartrate	Metoprolol Tartrate	101	19
Simvastatin	Simvastatin	96	19
Famotidine	Famotidine	92	16
Rosuvastatin Calcium	Rosuvastatin Calcium	89	12
Fluticasone Propionate	Fluticasone Propionate	88	19
Carvedilol	Carvedilol	87	16
Spironolactone	Spironolactone	84	14
Oxybutynin Chloride Er	Oxybutynin Chloride	80	11
Latanoprost	Latanoprost	79	13
Clopidogrel	Clopidogrel Bisulfate	78	suppressed
Ondansetron Hcl	Ondansetron Hcl	77	61
Montelukast Sodium	Montelukast Sodium	68	suppressed
Xarelto	Rivaroxaban	66	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	65	43
Hydralazine Hcl	Hydralazine Hcl	63	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	38
Nystatin	Nystatin	55	26
Myrbetriq	Mirabegron	54	suppressed
Citalopram Hbr	Citalopram Hydrobromide	51	suppressed
Duloxetine Hcl	Duloxetine Hcl	51	suppressed
Bupropion Xl	Bupropion Hcl	49	suppressed
Jardiance	Empagliflozin	49	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	47	33
Hydrochlorothiazide	Hydrochlorothiazide	44	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Pravastatin Sodium	Pravastatin Sodium	43	suppressed
Methenamine Hippurate	Methenamine Hippurate	42	suppressed
Cephalexin	Cephalexin	41	32
Levetiracetam	Levetiracetam	41	suppressed
Lorazepam	Lorazepam	40	23
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Loperamide	Loperamide Hcl	39	20
Albuterol Sulfate Hfa	Albuterol Sulfate	38	19
Atenolol	Atenolol	38	suppressed
Celecoxib	Celecoxib	37	suppressed
Divalproex Sodium	Divalproex Sodium	36	suppressed
Finasteride	Finasteride	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Memantine Hcl Er	Memantine Hcl	34	suppressed
Desonide	Desonide	33	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	33	suppressed
Humalog Kwikpen U-100	Insulin Lispro	32	suppressed
Olanzapine	Olanzapine	32	suppressed
Topiramate	Topiramate	31	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	21
Lovastatin	Lovastatin	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Entresto	Sacubitril/Valsartan	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Risperidone	Risperidone	28	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Prednisone	Prednisone	27	16
Alendronate Sodium	Alendronate Sodium	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Cefdinir	Cefdinir	24	17
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	24	suppressed
Baclofen	Baclofen	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Telmisartan	Telmisartan	23	suppressed
Azithromycin	Azithromycin	22	19
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	21
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Methimazole	Methimazole	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Valsartan	Valsartan	21	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Rivastigmine	Rivastigmine	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Digoxin	Digoxin	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Levofloxacin	Levofloxacin	17	15
Allopurinol	Allopurinol	16	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Eplerenone	Eplerenone	15	suppressed
Irbesartan	Irbesartan	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Clonazepam	Clonazepam	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Colesevelam Hcl	Colesevelam Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Glipizide	Glipizide	13	suppressed
Lactulose	Lactulose	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lithium Carbonate	Lithium Carbonate	13	suppressed
Rybelsus	Semaglutide	13	suppressed
Rytary	Carbidopa/Levodopa	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Anastrozole	Anastrozole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Estradiol	Estradiol	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Galantamine Hbr	Galantamine Hbr	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Rexulti	Brexpiprazole	11	suppressed
Sulfasalazine	Sulfasalazine	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error